Nordic Kinetics AB

Nordic Kinetics develops Sine Monitoring, a platform aiming to seamlessly diagnose and monitor patients with movement disorder.

By relying on devices patients already own, predominantly smartphones, we analyse sensor data to generate objective symptom profiles; these profiles can in turn be used to assess/optimise effects of medications, identify patients for advanced therapy (e.g. surgery) and help generate real world evidence for our device and pharma partners.

Our two products are CE marked (class I, class IIa underway), one has received FDA 510(k) clearance and one has been filed for FDA 510(k) clearance. A patent covering the core technologies has been filed. We are planning for a US launch this fall following FDA 510(k) approvals. The system will be reimbursable under Medicare.

The company was founded in 2025, FRST Capital led our pre-seed.